Beth Chaplin

Beth Chaplin

Auto-generated profile, based on publicly available information

Beth Chaplin

Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2006 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
AVAshwin Vasan
Ashwin Vasan
BRBoris Renjifo
Boris Renjifo
EHEllen Hertzmark
Ellen Hertzmark
BCBeth Chaplin
Beth Chaplin
GMGernard Msamanga
Gernard Msamanga
DHDavid Hunter
David Hunter
Background. Many different subtypes of human immunodeficiency virus (HIV) type 1 have been identified, particularly in sub-Saharan Africa. However, m

10 November 2011 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
HRHolly E. Rawizza
Holly E. Rawizza
BCBeth Chaplin
Beth Chaplin
SMSeema T. Meloni
Seema T. Meloni
GEGeoffrey Eisen
Geoffrey Eisen
TRTara Rao
Tara Rao
FTfor the APIN PEPFAR Team
for the APIN PEPFAR Team
Background. Viral load (VL) quantification is considered essential for determining antiretroviral treatment (ART) success in resource-rich countries. However, it is not widely available in resource-limited settings where the burden of human immunodeficiency virus infection is greatest. In the absence of VL monitoring, switches to second-line ART are based on World Health Organization (WHO) clinical or immunologic failure criteria. Methods. We assessed the performance of CD4 cell criteria to predict virologic outcomes in a large ART program in Nigeria. Laboratory monitoring consists of CD4 cell count and VL at baseline, then every 6 months. Failure was defined as 2 consecutive VLs >1000 copies/mL after at least 6 months of ART. Virologic outcomes were compared with the 3 WHO-defined immunologic failure criteria. Results. A total of 9690 patients were included in the analysis (median follow-up, 33.2 months). A total of 1225 patients experienced failure by both immunologic and virologic criteria, 872 by virologic criteria only, and 1897 by immunologic criteria only. The sensitivity of CD4 cell criteria to detect viral failure was 58%, specificity was 75%, and the positive-predictive value was 39%. For patients with both virologic and immunologic failure, VL criteria identified failure significantly earlier than CD4 cell criteria (median, 10.4 vs 15.6 months; P < .0001). Conclusions. Because of the low sensitivity of immunologic criteria, a substantial number of failures are missed, potentially resulting in accumulation of resistance mutations. In addition, specificity and predictive values are low, which may result in large numbers of unnecessary ART switches. Monitoring solely by immunologic criteria may result in increased costs because of excess switches to more expensive ART and development of drug-resistant virus.

1 August 2004 in AIDS
Verified
Journal Article
Closed access
BRBoris Renjifo
Boris Renjifo
PGPeter Gilbert
Peter Gilbert
BCBeth Chaplin
Beth Chaplin
GMGernard Msamanga
Gernard Msamanga
DMDavis Mwakagile
Davis Mwakagile
MEMax Essex
Max Essex
To determine whether different HIV-1 genotypes present in a single cohort, in Dar es Salaam, Tanzania, showed differences in timing for transmission from mothers to their infants. We determined the maternal viral load, transmission time, and the HIV-1 envelope (env) subtype of 253 HIV-1-infected infants enrolled in a randomized double-blind placebo-controlled trial to examine the efficacy of vitamins in decreasing mother-to-child transmission in Tanzania. Classification of HIV-1 positivity in utero was based on PCR results at birth. Infants were classified as intrapartum infected if they scored negative for the sample collected at birth and positive for the sample collected at 6 weeks of age. We found significant differences in the distribution of transmission time according to subtype. A higher proportion of HIV-1 with subtype C env (C-env) was transmitted in utero than HIV-1 with subtype A env (A-env), subtype D env (D-env), or both combined. The identification of patterns of mother-to-child transmission times among HIV-1 genotypes may be useful in the selection of drug regimens for chemoprophylaxis. Based on our results, the efficacy of regimens administered only at labor may not protect as large a fraction of infants born in geographical regions with subtype C-env epidemics as compared to epidemics in regions where subtypes A-env and D-env predominate in the population.

1 January 2006 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
IKIrene N Koulinska
Irene N Koulinska
EVEduardo Villamor
Eduardo Villamor
BCBeth Chaplin
Beth Chaplin
GMGernard Msamanga
Gernard Msamanga
WFWafaie Fawzi
Wafaie Fawzi
MEMax Essex
Max Essex
Transmission through breast-feeding is an important cause of infant HIV-1 infections in developing countries; however, its mechanism remains largely unknown. We have explored the association between cell-free virus (CFV) and cell-associated virus (CAV) levels in breast milk (BM), as reflected by viral RNA and proviral DNA, respectively, and the risk of infant HIV-1 infection after 6 weeks postpartum. Sixty-one HIV-positive mothers who transmitted HIV-1 by BM were matched to 61 HIV-positive nontransmitting mothers based on their infant's age at sample collection. CFV and CAV were quantified in a single milk specimen per mother preceding the infant's first HIV-positive result. After adjusting for maternal CD4+ cell counts and disease stage, each 10-fold increase in CFV or CAV load was associated with an almost 3-fold increase in BM transmission. Whereas CAV load was predictive of transmission before and after 9 months postpartum, CFV was a significant predictor of transmission occurring only after 9 months. Phylogenetic analyses of the C2 to C5 env region showed that 85% of infants (11 of 13 infants) harboring viruses that clustered with CFV in their mother's milk were infected after 9 months postpartum. A reduction in milk CAV and CFV loads might significantly decrease HIV-1 transmission by breast-feeding.

1 May 1998 in AIDS Research and Human Retroviruses
Verified
Journal Article
Closed access
BRBoris Renjifo
Boris Renjifo
BCBeth Chaplin
Beth Chaplin
DMDavis Mwakagile
Davis Mwakagile
PSPulin Shah
Pulin Shah
FVFredrik Vannberg
Fredrik Vannberg
MEMax Essex
Max Essex
The only peer-reviewed journal focused on the rapidly moving field of 3D printing and related technologies, providing comprehensive coverage of academic research and industrial and commercial developments that have applications in medicine, education, food, and architecture.

1 January 2015 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
BCBeth Chaplin
Beth Chaplin
SMSeema Meloni
Seema Meloni
GEGeoffrey Eisen
Geoffrey Eisen
TJToyin Jolayemi
Toyin Jolayemi
BBBolanle Banigbe
Bolanle Banigbe
PKPhyllis Jean Kanki
Phyllis Jean Kanki